Table 3.
Univariable | HARVEST-Malmö | GREAT Network Rome | Pooled cohort | ||||||
N=323 (30 events) | N=178 (37 events) | N=501 (67 events) | |||||||
OR | 95% CI | P value | OR | 95% CI | P value | OR | 95% CI | P value | |
Age | 0.98 | 0.95 to 1.02 | 0.299 | 1.01 | 0.97 to 1.04 | 0.715 | 1.00 | 0.98 to 1.03 | 0.932 |
Sex | 6.72 | 1.57 to 28.8 | 0.010 | 0.94 | 0.48 to 1.84 | 0.847 | 1.22 | 0.73 to 2.04 | 0.443 |
Diabetes | 1.40 | 0.65 to 3.03 | 0.389 | 1.12 | 0.56 to 2.2 | 0.751 | 1.23 | 0.74 to 2.04 | 0.425 |
SBP | 1.00 | 0.98 to 1.01 | 0.621 | 1.01 | 1.00 to 1.02 | 0.158 | 1.01 | 1.00 to 1.02 | 0.100 |
ACE-i | 0.72 | 0.34 to 1.52 | 0.384 | 1.32 | 0.66 to 2.64 | 0.432 | 0.83 | 0.51 to 1.37 | 0.468 |
ARB | 0.60 | 0.22 to 1.64 | 0.320 | 0.52 | 0.21 to 1.31 | 0.165 | 0.54 | 0.28 to 1.06 | 0.074 |
Betablockers | 1.32 | 0.38 to 4.56 | 0.665 | 1.20 | 0.61 to 2.36 | 0.590 | 0.81 | 0.47 to 1.39 | 0.444 |
Prior HF | 1.14 | 0.84 to 1.55 | 0.407 | 0.71 | 0.35 to 1.42 | 0.330 | 0.90 | 0.62 to 1.31 | 0.590 |
Creatinine | 2.73 | 1.79 to 4.18 | <0.001 | 1.16 | 0.83 to 1.62 | 0.396 | 1.63 | 1.28 to 2.08 | <0.001 |
BNP | 1.16 | 0.79 to 1.70 | 0.459 | 0.90 | 0.64 to 1.26 | 0.532 | 1.01 | 0.78 to 1.29 | 0.966 |
PenKid | 1.81 | 1.21 to 2.70 | 0.004 | 1.37 | 0.99 to 1.89 | 0.059 | 1.67 | 1.31 to 2.14 | <0.001 |
Multivariable | |||||||||
Age | 0.98 | 0.95 to 1.01 | 0.173 | ||||||
Sex | 1.54 | 0.80 to 2.98 | 0.197 | ||||||
Diabetes | 0.92 | 0.51 to 1.66 | 0.919 | ||||||
SBP | 1.00 | 0.99 to 1.01 | 0.373 | ||||||
ACEi | 0.80 | 0.43 to 1.50 | 0.483 | ||||||
ARB | 0.47 | 0.21 to 1.04 | 0.063 | ||||||
BB | 0.98 | 0.50 to 1.91 | 0.946 | ||||||
Prior HF | 1.02 | 0.72 to 1.43 | 0.926 | ||||||
BNP | 0.78 | 0.57 to 1.06 | 0.115 | ||||||
Creatinine | 1.68 | 0.69 to 4.05 | 0.251 | ||||||
PenKid | 1.74 | 1.20 to 2.53 | 0.004 |
Values are OR with 95% CI. Multivariable results are reported for the pooled cohort adjusted for variables known from literature.
ACE-I, ACE inhibitors;ARB, angiotensin receptor blocker;BNP, B-type natriuretic peptide;HARVEST, HeArt and bRain failure inVESTigation trial; HF, heart failure; SBP, systolic blood pressure; penKid, proenkephalin A 119–159.